Patents Assigned to Ocean Nutrition Canada Limited
  • Patent number: 6998501
    Abstract: Triglycerides and cholesterol in the bloodstream are important factors in the development of cardiovascular disease. The present invention discloses a nutritional supplement comprising a sterol and an omega-3 fatty acid, or an ester thereof, for lowering cholesterol and triglyceride levels in the bloodstream of a subject. Preferably, the sterol and omega-3 fatty acid are together in the form of an ester.
    Type: Grant
    Filed: August 30, 2000
    Date of Patent: February 14, 2006
    Assignee: Ocean Nutrition Canada Limited
    Inventors: Jeffrey L. C. Wright, Jaroslav A. Kralovec
  • Patent number: 6977076
    Abstract: Chlorella extracts containing high molecular weight Chlorella polysaccharide and polysaccharide complexes show immune modulatory, specifically immune stimulatory, activity. The polysaccharide and polysaccharide complexes contain glucose and any combination of: galactose, rhamnose, mannose and arabinose, as well as N-acetyl glucosamine and N-acetyl galactosamine. The extracts may be treated with pronase, DNAse, RNAse and proteases to remove unassociated nucleic acids, ribonucleic acids and proteins. The extracts may also undergo treatment to effect cleavage of specific glycosidic linkages, the linkages being defined by their susceptibility to cleavage by amylase, amyloglucosidase, cellulase or neuraminidase. Chlorella extracts may be administered to a mammal to increase proliferation of splenocytes and increase production of cytokines such as IL-6, IL-10, INF-? and TNF-?. They may be used as a supplement to a vaccination regimen.
    Type: Grant
    Filed: February 19, 2003
    Date of Patent: December 20, 2005
    Assignee: Ocean Nutrition Canada Limited
    Inventor: Jaroslav A. Kralovec
  • Patent number: 6974592
    Abstract: Microcapsules comprising an agglomeration of primary microcapsules, each individual primary microcapsule having a primary shell and the agglomeration being encapsulated by an outer shell, may be prepared by providing an aqueous mixture of a loading substance and a shell material, adjusting pH, temperature, concentration and/or mixing speed to form primary shells of shell material around the loading substance and cooling the aqueous mixture until the primary shells agglomerate and an outer shell of shell material forms around the agglomeration. Such microcapsules are useful for storing a substance and for delivering the substance to a desired environment.
    Type: Grant
    Filed: April 11, 2002
    Date of Patent: December 13, 2005
    Assignee: Ocean Nutrition Canada Limited
    Inventor: Nianxi Yan
  • Patent number: 6974576
    Abstract: Chlorella extracts containing high molecular weight Chlorella polysaccharide and polysaccharide complexes show immune modulatory, specifically immune stimulatory, activity. The polysaccharide and polysaccharide complexes contain glucose and any combination of: galactose, rhamnose, mannose and arabinose, as well as N-acetyl glucosamine and N-acetyl galactosamine. The extracts may be treated with pronase, DNAse, RNAse and proteases to remove unassociated nucleic acids, ribonucleic acids and proteins. The extracts may also undergo treatment to effect cleavage of specific glycosidic linkages, the linkages being defined by their susceptibility to cleavage by amylase, amyloglucosidase, cellulase or neuraminidase. Chlorella extracts may be administered to a mammal to increase proliferation of splenocytes and increase production of cytokines such as IL-6, IL-10, INF-? and TNF-?. They may be used as a supplement to a vaccination regimen.
    Type: Grant
    Filed: December 8, 2003
    Date of Patent: December 13, 2005
    Assignee: Ocean Nutrition Canada Limited
    Inventor: Jaroslav A. Kralovec
  • Publication number: 20050175711
    Abstract: Disclosed is a composition from shark cartilage comprising immunoactive proteoglycans and other immunoactive components having a molecular weight greater than about 100 KD, wherein the composition has a uronic acid content of about 0.05-0.5 ?g glucuronic acid per ?g of the composition. The composition may be useful for treating or preventing tumor growth, bacterial infections, viral infections and/or fungal infections.
    Type: Application
    Filed: February 15, 2002
    Publication date: August 11, 2005
    Applicant: Ocean Nutrition Canada Limited
    Inventors: Jaroslav Kralovec, Frank Sing
  • Patent number: 6926918
    Abstract: Bonito hydrolysate (e.g. katsuobushi oligopeptide (KO)) enhances the flavour of salt and may be used to replace salt in foods and beverages.
    Type: Grant
    Filed: March 11, 2002
    Date of Patent: August 9, 2005
    Assignee: Ocean Nutrition Canada Limited
    Inventor: Raynald Jacques LeBlanc
  • Patent number: 6632804
    Abstract: Compositions comprising ferrous ion and an ascorbate have a synergistic effect on cartilage development. Therapeutic compositions comprising ferrous ion and an ascorbate are therefore useful in the treatment of osteoarthritis. The addition of a glucosamine, such as glucosamine hydrochloride, to the composition has a further enhanced effect on cartilage production. Therapeutic compositions comprising ferrous ion, an ascorbate and a glucosamine derivative are even more useful in the treatment of osteoarthritis.
    Type: Grant
    Filed: April 25, 2001
    Date of Patent: October 14, 2003
    Assignee: Ocean Nutrition Canada Limited
    Inventor: V. G. Sunetra Ekanayake
  • Patent number: 6551596
    Abstract: Chlorella fractionated extracts containing high molecular weight Chlorella polysaccharide and polysaccharide complexes show immune modulatory, specifically immune stimulatory activity. The fractionated extracts are obtained by size fractionation of an extract of Chlorella and selecting fractions containing high molecular weight polysaccharides and polysaccharide complexes of about 1×104 Da to about 1×107 Da. A fraction of about 4×106 Da to about 1×107 Da is preferably obtained by size fractionation. The polysaccharide and polysaccharide complexes contain glucose and any combination of: galactose, rhamnose, mannose and arabinose, as well as N-acetyl glucosamine and N-acetyl galactosamine. The extracts may be treated with pronase, DNAse, RNAse and proteases to remove unassociated nucleic acids, ribonucleic acids and proteins.
    Type: Grant
    Filed: August 10, 2001
    Date of Patent: April 22, 2003
    Assignee: Ocean Nutrition Canada Limited
    Inventor: Jaroslav A. Kralovec